Transforming growth factor-β1 and matrix metalloproteinases in prostatic adenocarcinoma and hyperplasia: Coordinated patterns of immunohistochemical expression

Applied Immunohistochemistry and Molecular Morphology

Volumn 5, Issue 4, 1997, Pages 246-251

  Boag, A H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Matrix metalloproteases; Prostate cancer; Prostatic intraepithelial neoplasia; Stromelysin; Transforming growth factor 1; Type IV collagenase

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; SECRETORY CELL; STROMA CELL;

EID: 0031421348     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199712000-00007     Document Type: Article

References (19)

1. Isaacs JT. Molecular markers for prostate cancer metastasis: developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1997;150:1511-21.
2. Boag AH, Young ID. Increased expression of 72-kDa type IV collagenase is restricted to tumour cells in prostatic adenocarcinoma: demonstration by immunohistochemistry and in situ hybridization. Am J Pathol 1994;144:585-91.
3. Nagle RB, Petein M, Brawer M, Bowden GT, Cress AE. New relationships between prostatic intraepithelial neoplasia and prostatic carcinoma. J Cell Biol 1992;16H(Suppl):26-9.
4. Montironi R, Lucarini G, Castaldini C, Galluzzi CM, Biagini G, Fabris G. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Anticancer Res 1996;16:2057-62.
5. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT. Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991;117:144-50.
6. Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 1997;150:1571-82.
7. Rouyer N, Wolf C, Chenard MP, et al. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 1994;14: 269-75.
8. Hahnel E, Dawkins H, Robbins P, Hahnel R. Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues. Int J Cancer 1994;58:157-60.
9. Xie B, Dong Z, Fidler IJ. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J Immmol 1994;152:3637-14.
10. Agarwal C, Hembree JR, Rorke EA, Eckert RL. Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res 1994;54: 943-9.
11. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Opthalmol Vis Sci 1991;32:2441-54.
12. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC. Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. Hum Pathol 1993;24:4-9.
13. Eastham JA, Truong LD, Rogers E, et al. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest 1995; 73:628-35.
14. Kim IY, Ahn HJ, Zelner DJ, et al. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res 1996;56:44-8.
15. Knox JD, Wolf C, McDaniel K, et al. Matrilysin expression in human prostate carcinoma. Mol Carcinog 1996;15:57-63.
16. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
17. Pyke C, Ralfkiaer E, Tryggvason K, Dano K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-65.
18. Emmert-Buck MR, Emonard HP, Corcoran ML, Krutzsch HC, Foidart JM, Stetler-Stevenson WG. Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett 1995;364: 28-32.
19. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 1994;370:61-5.